Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Brain, Behavior, and Immunity|February 21, 2026
Gut microbiota and metabolite disruption during breast cancer chemotherapy is associated with peripheral neuropathy sensory symptoms and painJeremy T Beales, Varshasnata Mohanty, Melina M Seng, et al.Psychoneuroendocrinology|March 22, 2025
The role of oxytocin in mediating the relationships between social factors and chemotherapy-associated cognitive decline in female patients with breast cancerMelina M Seng, Seth Adarkwah Yiadom, Lauren D Otto-Dobos, et al.Pain|March 21, 2023
Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increasesAnnelise A Madison, Megan Renna, Rebecca Andridge, et al.Brain, Behavior, and Immunity|April 4, 2022
Breast cancer survivors' typhoid vaccine responses: Chemotherapy, obesity, and fitness make a differenceJanice K Kiecolt-Glaser, Megan Renna, Juan Peng, et al.Journal of Behavioral Medicine|November 2, 2020
Worry and rumination in breast cancer patients: perseveration worsens self-rated healthMegan E Renna, M Rosie Shrout, Annelise A Madison, et al.Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 19, 2023
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover TrialMegan E Renna, Annelise A Madison, Juan Peng, et al.Genome Medicine|May 21, 2021
Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancerZachary T Weber, Katharine A Collier, David Tallman, et al.International Journal of Behavioral Medicine|July 13, 2022
Distress Disorder Histories Relate to Greater Physical Symptoms Among Breast Cancer Patients and Survivors: Findings Across the Cancer TrajectoryMegan E Renna, M Rosie Shrout, Annelise A Madison, et al.Cancers|January 11, 2024
Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain MetastasesRituraj Upadhyay, Brett G Klamer, Haley K Perlow, et al.Therapeutic Advances in Medical Oncology|December 28, 2023
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancerNicole O Williams, Dionisia Quiroga, Courtney Johnson, et al.Pageof 3